期刊论文详细信息
BMC Psychiatry
Evaluating the efficacy and cost-effectiveness of web-based indicated prevention of major depression: design of a randomised controlled trial
Matthias Berking1  Filip Smit4  Heleen Riper3  Pim Cuijpers3  Dirk Lehr2  David D Ebert1  Claudia Buntrock3 
[1]Department of Psychology, Clinical Psychology and Psychotherapy, Philipps University Marburg, Marburg, Germany
[2]Innovation Incubator, Division Health Training Online, Leuphana University, Lueneburg, Germany
[3]Department of Clinical Psychology and EMGO Institute for Health and Care Research, VU University, Amsterdam, The Netherlands
[4]Department of Epidemiology and Biostatistics, EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, The Netherlands
关键词: Cost-effectiveness;    Major depression;    Randomised controlled trial;    Subthreshold depression;    Web-based;    Indicated;    Prevention;   
Others  :  1123809
DOI  :  10.1186/1471-244X-14-25
 received in 2013-06-28, accepted in 2014-01-27,  发布年份 2014
PDF
【 摘 要 】

Background

Major depressive disorder (MDD) imposes a considerable disease burden on individuals and societies. Web-based interventions have shown to be effective in reducing depressive symptom severity. However, it is not known whether web-based interventions may also be effective in preventing the onset of MDD. The aim of this study is to evaluate the (cost-) effectiveness of an indicated web-based guided self-help intervention (GET.ON Mood Enhancer Prevention) on the onset of MDD.

Methods/Design

A randomised controlled trial (RCT) will be conducted to compare the (cost-) effectiveness of the GET.ON Mood Enhancer Prevention training with a control condition exclusively receiving online-based psychoeducation on depression. Adults with subthreshold depression (N = 406) will be recruited from the general population and randomised to one of the two conditions. The primary outcome is time to onset of MDD within a 12-months follow-up period. MDD will be assessed according to DSM-IV criteria as assessed by the telephone-administered Structured Clinical Interview for DSM-IV (SCID). Time to onset of MDD will be assessed using life charts. Secondary outcomes include changes on various indicators of depressive symptom severity, anxiety and quality of life from baseline to post-treatment, to a 6-month and a 12-month follow up. Additionally, an economic evaluation using a societal perspective will be conducted to examine the intervention’s cost-effectiveness.

Discussion

This is one of the first randomised controlled trials that examines the effect of an indicated guided self-help web-based intervention on the incidence of major depression. If shown to be effective, the intervention will contribute to reducing the disease burden due to MDD in the general population.

Trial registration

German Clinical Trial Registration DRKS00004709.

【 授权许可】

   
2014 Buntrock et al.; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20150216044341147.pdf 681KB PDF download
Figure 1. 72KB Image download
【 图 表 】

Figure 1.

【 参考文献 】
  • [1]Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, Bryson H, De Girolamo G, Graaf R, Demyttenaere K, Gasquet I, Haro JM, Katz SJ, Kessler RC, Kovess V, Lepine JP, Ormel J, Polidori G, Russo LJ, Vilagut G, Almansa J, Arbabzadeh-Bouchez S, Autonell J, Bernal M, Buist-Bouwman MA, Codony M, Domingo-Salvany A, Ferrer M, Joo SS, Martinez-Alonso M, Matschinger H, et al.: Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl 2004, 420:21-27.
  • [2]Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kendler KS: Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the national comorbidity survey. Arch Gen Psychiatry 1994, 51(1):8-19.
  • [3]Waraich P, Goldner EM, Somers JM, Hsu L: Prevalence and incidence studies of mood disorders: a systematic review of the literature. Can J Psychiatry 2004, 49(2):124-138.
  • [4]Ferrari AJ, Somerville AJ, Baxter AJ, Norman R, Patten SB, Vos T, Whiteford HA: Global variation in the prevalence and incidence of major depressive disorder: a systematic review of the epidemiological literature. Psychol Med 2013, 43(3):471-481.
  • [5]Ustun TB, Ayuso-Mateos JL, Chatterji S, Mathers C, Murray CJ: Global burden of depressive disorders in the year 2000. Br J Psychiatry 2004, 184:386-392.
  • [6]Saarni SI, Suvisaari J, Sintonen H, Pirkola S, Koskinen S, Aromaa A, Lonnqvist J: Impact of psychiatric disorders on health-related quality of life: general population survey. Br J Psychiatry 2007, 190:326-332.
  • [7]Cuijpers P, Smit F: Excess mortality in depression: a meta-analysis of community studies. J Affect Disord 2002, 72(3):227-236.
  • [8]Berto P, D’Ilario D, Ruffo P, Di Virgilio R, Rizzo F: Depression: cost-of-illness studies in the international literature, a review. J Ment Health Policy Econ 2000, 3(1):3-10.
  • [9]Greenberg PE, Birnbaum HG: The economic burden of depression in the US: societal and patient perspectives. Expert Opin Pharmacother 2005, 6(3):369-376.
  • [10]Smit F, Cuijpers P, Oostenbrink J, Batelaan N, de Graaf R, Beekman A: Costs of nine common mental disorders: implications for curative and preventive psychiatry. J Ment Health Policy Econ 2006, 9(4):193-200.
  • [11]Mathers CD, Loncar D: Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006, 3(11):e442.
  • [12]Richards D, Richardson T: Computer-based psychological treatments for depression: a systematic review and meta-analysis. Clin Psychol Rev 2012, 32(4):329-342.
  • [13]Cuijpers P, van Straten A, Andersson G, van Oppen P: Psychotherapy for depression in adults: a meta-analysis of comparative outcome studies. J Consult Clin Psychol 2008, 76(6):909-922.
  • [14]Cuijpers P, van Straten A, Warmerdam L, Andersson G: Psychological treatment of depression: a meta-analytic database of randomized studies. BMC Psychiatry 2008, 8:36. BioMed Central Full Text
  • [15]Tylee A, Jones R: Managing depression in primary care. BMJ 2005, 330(7495):800-801.
  • [16]Andrews G, Issakidis C, Sanderson K, Corry J, Lapsley H: Utilising survey data to inform public policy: comparison of the cost-effectiveness of treatment of ten mental disorders. Br J Psychiatry 2004, 184:526-533.
  • [17]Chisholm D, Sanderson K, Ayuso-Mateos JL, Saxena S: Reducing the global burden of depression: population-level analysis of intervention cost-effectiveness in 14 world regions. Br J Psychiatry 2004, 184:393-403.
  • [18]Cuijpers P, van Straten A, Smit F, Mihalopoulos C, Beekman A: Preventing the onset of depressive disorders: a meta-analytic review of psychological interventions. Am J Psychiatry 2008, 165(10):1272-1280.
  • [19]Willemse GR, Smit F, Cuijpers P, Tiemens BG: Minimal-contact psychotherapy for sub-threshold depression in primary care: randomised trial. British J Psychiatry 2004, 185:416-421.
  • [20]Schoevers RA, Smit F, Deeg DJ, Cuijpers P, Dekker J, van Tilburg W, Beekman AT: Prevention of late-life depression in primary care: do we know where to begin? Am J Psychiatry 2006, 163(9):1611-1621.
  • [21]Cuijpers P: Minor depression: risk profiles, functional disability, health care use and risk of developing major depression. J Affect Disord 2004, 79(1–3):71-79.
  • [22]Backenstrass M, Frank A, Joest K, Hingmann S, Mundt C, Kronmuller KT: A comparative study of nonspecific depressive symptoms and minor depression regarding functional impairment and associated characteristics in primary care. Compr Psychiatry 2006, 47(1):35-41.
  • [23]Cuijpers P, Smit F, Oostenbrink J, de Graaf R, Ten Have M, Beekman A: Economic costs of minor depression: a population-based study. Acta Psychiatr Scand 2007, 115(3):229-236.
  • [24]Cuijpers P, Smit F: Subthreshold depression as a risk indicator for major depressive disorder: a systematic review of prospective studies. Acta Psychiatr Scand 2004, 109(5):325-331.
  • [25]Morgan AJ, Jorm AF, Mackinnon AJ: Email-based promotion of self-help for subthreshold depression: mood memos randomised controlled trial. Br J Psychiatry 2012, 200(5):412-418.
  • [26]Christensen H, Griffiths KM: The prevention of depression using the Internet. Med J Aust 2002, 177(Suppl):S122-S125.
  • [27]Cuijpers P, van Straten A, Warmerdam L, van Rooy MJ: Recruiting participants for interventions to prevent the onset of depressive disorders: possible ways to increase participation rates. BMC Health Serv Res 2010, 10:181. BioMed Central Full Text
  • [28]Klaw E, Humphreys K: Facilitating client involvement in self-help groups. In Psychologists’ desk reference. 2nd edition. Edited by Koocher G, Norcross J, Hill S. New York: Oxford University Press; 2005:502-505.
  • [29]Meyer B, Berger T, Caspar F, Beevers CG, Andersson G, Weiss M: Effectiveness of a novel integrative online treatment for depression (Deprexis): randomized controlled trial. J Med Internet Res 2009, 11(2):e15.
  • [30]Cavanagh K, Seccombe N, Lidbetter N: The implementation of computerized cognitive behavioural therapies in a service user-led, third sector self help clinic. Behav Cogn Psychother 2011, 39(4):427-442.
  • [31]Spek V, Nyklicek I, Smits N, Cuijpers P, Riper H, Keyzer J, Pop V: Internet-based cognitive behavioural therapy for subthreshold depression in people over 50 years old: a randomized controlled clinical trial. Psychol Med 2007, 37(12):1797-1806.
  • [32]Calear AL, Christensen H, Mackinnon A, Griffiths KM, O’Kearney R: The YouthMood Project: a cluster randomized controlled trial of an online cognitive behavioral program with adolescents. J Consult Clin Psychol 2009, 77(6):1021-1032.
  • [33]Hoek W, Schuurmans J, Koot HM, Cuijpers P: Effects of Internet-based guided self-help problem-solving therapy for adolescents with depression and anxiety: a randomized controlled trial. PLoS One 2012, 7(8):e43485.
  • [34]de Graaf LE, Gerhards SA, Arntz A, Riper H, Metsemakers JF, Evers SM, Severens JL, Widdershoven G, Huibers MJ: Clinical effectiveness of online computerised cognitive-behavioural therapy without support for depression in primary care: randomised trial. Br J Psychiatry 2009, 195(1):73-80.
  • [35]Kupfer DJ: Long-term treatment of depression. J Clin Psychiatry 1991, 52(Suppl):28-34.
  • [36]GesundheitsTraining.Online http://www.geton-training.de webcite
  • [37]Rohde P, Lewinsohn PM, Seeley JR: Comparability of telephone and face-to-face interviews in assessing axis I and II disorders. Am J Psychiatry 1997, 154(11):1593-1598.
  • [38]Allen K, Cull A, Sharpe M: Diagnosing major depression in medical outpatients: acceptability of telephone interviews. J Psychosom Res 2003, 55(4):385-387.
  • [39]Lewinsohn PM: The behaviroal study and treatment of depression. In Progress in behavior modification. 1st edition. Edited by Hersen M, Eisler RM, Miller PM. New York: Academic Press; 1974.
  • [40]D’Zurilla TJ, Nezu AM: Social problem solving in adults. In Advances in cognitive-behavioral research and therapy. 1st edition. Edited by Kendall PC. New York: Academic Press; 1982:201-274.
  • [41]Cuijpers P, Smit F, van Straten A: Psychological treatments of subthreshold depression: a meta-analytic review. Acta Psychiatr Scandinavica 2007, 115(6):434-441.
  • [42]Garber J, Clarke GN, Weersing VR, Beardslee WR, Brent DA, Gladstone TR, DeBar LL, Lynch FL, D’Angelo E, Hollon SD, Shamseddeen W, Iyengar S: Prevention of depression in at-risk adolescents: a randomized controlled trial. JAMA 2009, 301(21):2215-2224.
  • [43]van’t Veer-Tazelaar PJ, van Marwijk HW, van Oppen P, van Hout HP, van der Horst HE, Cuijpers P, Smit F, Beekman AT: Stepped-care prevention of anxiety and depression in late life: a randomized controlled trial. Arch Gen Psychiatry 2009, 66(3):297-304.
  • [44]Warmerdam L, van Straten A, Twisk J, Riper H, Cuijpers P: Internet-based treatment for adults with depressive symptoms: randomized controlled trial. J Med Internet Res 2008, 10(4):e44.
  • [45]van Straten A, Cuijpers P, Smits N: Effectiveness of a web-based self-help intervention for symptoms of depression, anxiety, and stress: randomized controlled trial. J Med Internet Res 2008, 10(1):e7.
  • [46]Donker T, Griffiths KM, Cuijpers P, Christensen H: Psychoeducation for depression, anxiety and psychological distress: a meta-analysis. BMC Med 2009, 7:79. BioMed Central Full Text
  • [47]German S3-Guideline/National Disease Management Guideline Unipolar Depression http://www.depression.versorgungsleitlinien.de/ webcite
  • [48]Allart-van Dam E, Hosman CM, Hoogduin CA, Schaap CP: Prevention of depression in subclinically depressed adults: follow-up effects on the ‘Coping with Depression’ course. J Affect Dis 2007, 97(1–3):219-228.
  • [49]Clarke GN, Hawkins W, Murphy M, Sheeber LB, Lewinsohn PM, Seeley JR: Targeted prevention of unipolar depressive disorder in an at-risk sample of high school adolescents: a randomized trial of a group cognitive intervention. J Am Acad Child Adolesc Psychiatry 1995, 34(3):312-321.
  • [50]Hagan R, Evans SF, Pope S: Preventing postnatal depression in mothers of very preterm infants: a randomised controlled trial. BJOG 2004, 111(7):641-647.
  • [51]Lobbestael J, Leurgans M, Arntz A: Inter-rater reliability of the structured clinical interview for DSM-IV Axis I disorders (SCID I) and axis II disorders (SCID II). Clin Psychol Psychother 2011, 18(1):75-79.
  • [52]Crippa JA, de Lima OF, Del-Ben CM, Filho AS, da Silva Freitas MC, Loureiro SR: Comparability between telephone and face-to-face structured clinical interview for DSM-IV in assessing social anxiety disorder. Perspect Psychiatr Care 2008, 44(4):241-247.
  • [53]Hautzinger M, Bailer M, Hofmeister D, Keller F: Allgemeine Depressionsskala. 2nd edition. Göttingen: Hogrefe; 2012.
  • [54]Brooks R: EuroQol: the current state of play. Health Policy 1996, 37(1):53-72.
  • [55]Gandek B, Ware JE, Aaronson NK, Apolone G, Bjorner JB, Brazier JE, Bullinger M, Kaasa S, Leplege A, Prieto L, Sullivan M: Cross-validation of item selection and scoring for the SF-12 health survey in nine countries: results from the IQOLA project: international quality of life assessment. J Clin Epidemiol 1998, 51(11):1171-1178.
  • [56]Zigmond AS, Snaith RP: The hospital anxiety and depression scale. Acta Psychiatr Scand 1983, 67(6):361-370.
  • [57]Hermann-Lingen C, Buss U, Snaith RP: Hospital Anxiety and Depression Scale - Deutsche Version (HADS-D). 3rd edition. Bern: Verlag Hans Huber; 2011.
  • [58]Bjelland I, Dahl AA, Haug TT, Neckelmann D: The validity of the hospital anxiety and depression scale: an updated literature review. J Psychosom Res 2002, 52(2):69-77.
  • [59]D’Zurilla TJ, Nezu AM, Maydeu-Olivares A: Social Problem-Solving Inventory-Revised (SPSI-R). New York: MHS; 2002.
  • [60]Manos RC, Kanter JW, Luo W: The behavioral activation for depression scale-short form: development and validation. Behav Ther 2011, 42(4):726-739.
  • [61]Pearlin LI, Schooler C: The structure of coping. J Health Soc Behav 1978, 19(1):2-21.
  • [62]Berle D, Starcevic V, Moses K, Hannan A, Milicevic D, Sammut P: Preliminary validation of an ultra-brief version of the Penn State worry questionnaire. Clin Psychol Psychother 2011, 18(4):339-346.
  • [63]Bastien CH, Vallieres A, Morin CM: Validation of the insomnia severity index as an outcome measure for insomnia research. Sleep Med 2001, 2(4):297-307.
  • [64]Morin CM, Belleville G, Belanger L, Ivers H: The insomnia severity index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep 2011, 34(5):601-608.
  • [65]Devilly GJ, Borkovec TD: Psychometric properties of the credibility/expectancy questionnaire. J Behav Ther Exp Psychiatry 2000, 31(2):73-86.
  • [66]Fischer EH, Farina A: Attitudes toward seeking professional psychological help: a shortened form and considerations for research. J Coll Stud Dev 1995, 36:368-373.
  • [67]Elhai JD, Schweinle W, Anderson SM: Reliability and validity of the attitudes toward seeking professional psychological help scale-short form. Psychiatry Res 2008, 159(3):320-329.
  • [68]Schmidt J, Lamprecht F, Wittmann W: Satisfaction with inpatient management: development of a questionnaire and initial validity studies: [Article in German]. Psychother, Psychosom Med Psychol 1989, 39:248-255.
  • [69]Nguyen TD, Attkisson CC, Stegner BL: Assessment of patient satisfaction: development and refinement of a service evaluation questionnaire. Eval Program Plann 1983, 6(3–4):299-313.
  • [70]Attkisson CC, Zwick R: The client satisfaction questionnaire: psychometric properties and correlations with service utilization and psychotherapy outcome. Eval Program Plann 1982, 5(3):233-237.
  • [71]Nestoriuc Y, Rief W: Risiken und Nebenwirkungen von Psychotherapie [Risks and side-effects of psychotherapy]. In Risiken und Nebenwirkungen von Verhaltenstherapie [Risks and side-effects of behavioural therapy]. Edited by Linden M, Strauß B. Berlin: MWV; 2012:59-74.
  • [72]Dolan P: Modeling valuations for EuroQol health states. Med Care 1997, 35(11):1095-1108.
  • [73]Greiner W, Claes C, Busschbach JJ, von der Schulenburg JM: Validating the EQ-5D with time trade off for the German population. Eur J Health Econ 2005, 6(2):124-130.
  • [74]Brazier J, Roberts J, Tsuchiya A, Busschbach J: A comparison of the EQ-5D and SF-6D across seven patient groups. Health Econ 2004, 13(9):873-884.
  • [75]Brazier JE, Roberts J: The estimation of a preference-based measure of health from the SF-12. Med Care 2004, 42(9):851-859.
  • [76]Brazier J, Rowen D, Hanmer J: Revised SF-6D scoring programmes: a summary of improvements. PRO Newsletter 2008, 40:14-15.
  • [77]Hakkaart-van Roijen L, van Straten A, Donker M, Tiemens B: Manual Trimbos/iMTA questionnaire for Costs associated with Psychiatric illness (TiC-P). Rotterdam: Erasmus University; 2002.
  • [78]Association of Statutory Health Insurance Physicians http://www.kvberlin.de/20praxis/30abrechnung_honorar/10ebm/index.html webcite
  • [79]Krauth C, Hessel F, Hansmeier T, Wasem J, Seitz R, Schweikert B: Empirical standard costs for health economic evaluation in Germany – a proposal by the working group methods in health economic evaluation. Gesundheitswesen 2005, 67(10):736-746.
  • [80]Manca A, Hawkins N, Sculpher MJ: Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility. Health Econ 2005, 14(5):487-496.
  • [81]Fenwick E, O’Brien BJ, Briggs A: Cost-effectiveness acceptability curves–facts, fallacies and frequently asked questions. Health Econ 2004, 13(5):405-415.
  • [82]Christensen H, Griffiths KM, Farrer L: Adherence in internet interventions for anxiety and depression. J Med Internet Res 2009, 11(2):e13.
  文献评价指标  
  下载次数:7次 浏览次数:14次